Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
Medtronic
Mallinckrodt
Moodys

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Oxamic Acid


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Oxamic Acid?

Oxamic Acid is an investigational drug.

There have been 139 clinical trials for Oxamic Acid. The most recent clinical trial was a Phase 3 trial, which was initiated on February 12th 2013.

The most common disease conditions in clinical trials are Lymphoma, Leukemia, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are National Cancer Institute (NCI), Merck Sharp & Dohme Corp., and M.D. Anderson Cancer Center.

There is one US patent protecting this investigational drug and eight international patents.

Recent Clinical Trials for Oxamic Acid
TitleSponsorPhase
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast CancerMerck Sharp & Dohme Corp.Phase 2
Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast CancerUniversity of California, San FranciscoPhase 2
Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2

See all Oxamic Acid clinical trials

Clinical Trial Summary for Oxamic Acid

Top disease conditions for Oxamic Acid
Top clinical trial sponsors for Oxamic Acid

See all Oxamic Acid clinical trials

US Patents for Oxamic Acid

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Oxamic Acid ⤷  Try it Free Process for the preparation of oxalyl- and oxamyl-hydrazides Enichim ANIC S.p.A. (Palermo, IT) ⤷  Try it Free
Oxamic Acid ⤷  Try it Free Novel fluorinated resorcinol ethers and their use as anti-allergics and anti-inflammatories Ciba-Geigy Corporation (Ardsley, NY) ⤷  Try it Free
Oxamic Acid ⤷  Try it Free Simultaneous assay for glucose and urea Abbott Laboratories (Abbott Park, IL) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
McKesson
Medtronic
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.